How to Buy Angiodynamics Stock
Angiodynamics Inc
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally.
Angiodynamics stock last closed at $9.19, down 1.08% from the previous day, and has increased 58.72% in one year. It has overperformed other stocks in the Medical Instruments & Supplies industry by 1.01 percentage points. Angiodynamics stock is currently +68.01% from its 52-week low of $5.47, and -31.93% from its 52-week high of $13.50.
There are currently 40.61M shares of ANGO outstanding. The market value of ANGO is $373.18M. In the last 24 hours, 306,595 ANGO shares were traded.
How to Buy Angiodynamics Stock
Wondering how to invest in Angiodynamics stock? Here's how.
- Choose where to buy Angiodynamics stock: You need to choose a stock brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you figure out where to buy Angiodynamics stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Put funds into your brokerage account: Select your payment method and add your information.
- Analyze Angiodynamics stock: The Angiodynamics ticker symbol is ANGO. Is Angiodynamics stock a good investment? Should you buy shares of ANGO? How do ANGO's underlying business fundamentals look? Do top analysts think Angiodynamics is a good buy? Why has ANGO's stock price moved recently? (Hint: Our stock analysis website can help you evaluate if ANGO is a good stock to buy).
- Place your ANGO purchase: Decide if you will purchase ANGO shares at the current market price or use a limit order to purchase ANGO shares at a given price.
- Watch your investment in ANGO: Create a watchlist to keep track of your new investment in Angiodynamics shares.
Step 1: Choose where to buy Angiodynamics stock
You will need an online brokerage account to access the NASDAQ market and buy ANGO shares.
Our recommended brokerage: eToro
Based on our experience, eToro is the best online stock brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global financial markets: From Tech to Financial Services, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've picked the best brokerage, it's time to fill out some personal details so you are able to buy ANGO stock today.
How to Start a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to create your new brokerage account.
- Submit your info by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you've filled out your info on the best stock market app for beginners, you need to deposit funds:
Watch the walkthrough below if you need help transferring funds into your new brokerage account.
Step 4: Analyze Angiodynamics stock
After you have identified the best place to buy Angiodynamics stock, it's critical to analyze their stock prior to buying, so you can wrap your head around the risk as well as the opportunity.
Angiodynamics shares data
Fundamentals of Angiodynamics
WallStreetZen was built to help part-time investors perform more in-depth fundamental analysis in less time.
You can view all of the due diligence checks on ANGO's stock page.
Is ANGO stock overvalued?
You can use many financial metrics, analyses, models, and charts to gauge ANGO's true value.
Using relative valuations measures:
- ANGO could be undervalued based on its P/B ratio of 2.01x, relative to Medical Instruments & Supplies industry P/B ratio of 3.63x
You can do more valuation analysis on ANGO's stock here.
ANGO Financial Summary
Signs that ANGO is financially healthy:
- There are more short-term assets than short-term liabilities on the ANGO balance sheet.
- ANGO profit margin has gone up from -59.4% to -14.6% in the past year.
- ANGO has cash burn of 33829000. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the ANGO balance sheet.
Signs that ANGO is not financially healthy:
- ANGO has a relatively high debt to equity ratio of 0.54.
- Total ANGO debt is higher than 5 years ago, relative to shareholder equity.
- ANGO has $44.76M in cash and short term investments. This is not enough to cover its annual cash burn of $33.83M.
Is ANGO stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 1 sell side analysts who give forecasts on ANGO, the consensus analyst rating on Angiodynamics is a Buy
It's important to note that analyst ratings are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are projecting on the Angiodynamics stock forecast page.
ANGO Trading Indicators
Is ANGO Growing Revenue?
Last year, ANGO revenue was $283.32M. In the past five year, ANGO's revenue has gone up by 0.45% per year. This was slower than the Medical Instruments & Supplies industry average of 9.87%.
You can analyze ANGO's earnings and revenue performance here.
Latest Insiders Trades at ANGO
In the last 12 months, insiders at ANGO have sold more shares than they have bought.
Warren Nighan Jr., SVP Quality and Regulatory of ANGO, was the latest ANGO insider to sell. They sold $49,978.60 worth of ANGO shares on Jan 16, 2025.
Learn more about who owns ANGO stock here.
Can I rely on ANGO as an income stream?
No, Angiodynamics doesn't provide an income stream by paying out dividends.
ANGO Social Trading Data
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Place your ANGO purchase
There are two main options:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are usually sufficient. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a particular price limit, use a limit order.
Hit the Open Trade button and eToro will place the order.
If you need additional help with buying stocks on eToro, click the how to video below:
Step 6: Watch your investment in ANGO
Now that you own some shares in ANGO, you'll want to stay up-to-date on your new investment.
Add ANGO to a watchlist to monitor your ANGO stock.
ANGO Feed
How to Buy Stock in Angiodynamics
To reiterate, here are the 6 steps to buy stock in Angiodynamics:
- Choose where to buy Angiodynamics stock
- Create your brokerage account
- Put funds into your brokerage account
- Analyze Angiodynamics stock
- Place your ANGO purchase
- Watch your investment in ANGO
If you require a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you want to watch your investment in Angiodynamics, create a watchlist today.
Trending Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.